多不饱和脂肪酸与IgA肾病的研究进展
摘要
自1984年日本学者报道了鱼油能降低IgA肾病(IgA nephropathy,IgAN)患者蛋白尿这一结果[1]以来,激起了世界各地学者的研究热情。研究表明ω-3多不饱和脂肪酸(ω-3 polyunsaturated fatty acidsω-3PUFAs)能抑制导致肾脏疾病的炎症反应。但尚未取得一致的结论,
出处
《北京医学》
CAS
2012年第4期316-319,共4页
Beijing Medical Journal
参考文献29
-
1Hamazaki T,Tateno S,Sbisbido H. Eicosapentaneoic acid and IgA nephropathy[J].Lancet,1984,(8384):1017-1018.
-
2Fassett RG,Gobe G C,Peake JM. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease[J].American Journal of Kidney Diseases,2010.728-742.
-
3王海燕.肾脏病学[M]北京:人民卫生出版社,2008993-1016.
-
4Dong W,Pestka JJ. Persistent dysregulation of IgA production and IgA nephropathy in the B6C3F1 mouse following withdrawal of dietary vomitoxin (deoxynivalenol)[J].Fundamental and Applied Toxicology,1993.38-47.
-
5Pestka J J,Zhou HR. Interleukin-6-deficient mice refractory to IgA dysregulation but not anorexia induction by vomitoxin (Deoxynivalenol) ingestion[J].Food and Chemical Toxicology,2000,(7):565-575.doi:10.1016/S0278-6915(00)00041-7.
-
6Jia Q,Shi Y,Bennink MB. Docosahexaenoic acid and eicosapentaenoic acid,but not alpha-linolenic acid,suppress deoxynivalenol-induced experimental IgA nephropathy in mice[J].Journal of Nutrition,2004.1353-1361.
-
7Jia QS,Zhou HR,Bennink M. Docosahexaenoic acid attenuates mycotoxin-induced immunoglobulin a nephropathy,interleukin-6 transcription,and mitogen-activated protein kinase phosphorylation in mice[J].Journal of Nutrition,2004.3343-3349.
-
8Jia Q,Zhou HR,Shi Y. Docosahexaenoic acid consumption inhibits deoxynivalenol-induced CREB/ATF1 activation and IL-6 gene transcription in mouse macrophages[J].Journal of Nutrition,2006.366-372.
-
9Shi Y,Pestka JJ. Mechanisms for suppression of interleukin-6 expression in peritoneal macrophages from docosahexaenoic acid-fed mice[J].Journal of Nutritional Biochemistry,2009.358-368.
-
10Brown SA,Brown CA,Crowell WA. Effects of dietary polyunsaturated fatty acid supplementation in early renal insufficiency in dogs[J].Journal of Laboratory and Clinical Medicine,2000.275-286.
二级参考文献16
-
1Reich NH,Troyanov S,Scholey JW,et al.Remission of proteinuria improves prognosis in IgA nephropathy.J Am Soc Nephrol,2007,18:3177-3183.
-
2Hamazaki T,Tateno S,Sbisbido H.Eicosapentaneoic acid and IgA nephropathy.Lancet,1984,1(8384):1017-1018.
-
3Cheng IK,Chan PC,Chan MK.The effect of fish-oil dietary supplement on the progression of mesangial IgA glomerulonephritis.Nephrol Dial Transplant,1990,5:241-246.
-
4Parinyasiri U,Ong-Ajyooth L,Parichatikanond P,et al.Effect of fish oil on oxidative stress,lipid profile and renal function in IgA nephropathy.J Med Assoc Thai,2000,87:143-149.
-
5Hogg PJ,Lee J,Nardelli N,et al.Clinical Trial to Evaluate Omega-3 Fatty Acids and Alternate Day Prednisone in Patients with IgA Nephropathy:Report from the Southwest Pediatric Nephrology Study Group.J Am Soc Nephrol,2006,1:467-474.
-
6Bennett WM,Walker RG,Kincaid-Smith P.Treatment of IgA nephropathy with eicosapentanoic acid (EPA):a twoyear prospective trial.Clin Nephrol,1989,31:128-131.
-
7Pettersson EE,Rekola S,Berglund L,et al.Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids:a prospective,double-blind,randomized study.Clin Nephrol,1994,41:183-190.
-
8Donadio JV Jr,Grande JP,Bergstralh EJ,et al.The longterm outcome of patients with IgA nephropathy treated with fish oil in a controlled trial.J Am Soc Nephrol,1999,10:1772-1777.
-
9Branten AJ,Klasen IS,Wetzels JF.Short-term effects of fish oil treatment on urinary excretion of high-and lowmolecular weight proteins in patients with IgA nephropathy.Clin Nephrol,2002,58:267-274.
-
10Alexopoulos E,Stangou M,Pantzaki A,et al.Treatment of severe IgA nephropathy with omega-3 fatty acids:the effect of a "very low dose" regimen.Ren Fail,2004,26:453-459.
共引文献6
-
1沈琪,欧阳小林,黄献文,杨彤,黄贤贵,朱玉宸.抗高血压类药物治疗IgA肾病的Meta分析[J].中国全科医学,2013,16(8):904-910. 被引量:7
-
2邢妃中,王刚.IgA肾病的治疗进展[J].中国当代医药,2011,18(19):14-16. 被引量:6
-
3刘金彦,周清华,周生国,赵宇亮,李峥,张凌,付平.中文期刊发表的肾脏病领域Meta分析类论文的现状[J].中华肾脏病杂志,2013,29(6):471-473. 被引量:1
-
4刘丹,王彩丽.IgA肾病治疗进展[J].中外医疗,2014,33(32):189-191. 被引量:2
-
5胡妍琦,李六生.IgA肾病残余蛋白尿非免疫抑制剂药物治疗进展[J].中国医药导报,2018,15(15):34-37. 被引量:1
-
6费丹,朱斌.IgA肾病的治疗进展[J].中国中西医结合肾病杂志,2019,20(3):277-279. 被引量:7
-
1刘丹,王彩丽.IgA肾病治疗进展[J].中外医疗,2014,33(32):189-191. 被引量:2
-
2秦薇.多不饱和脂肪酸摄入量与肿瘤的相关分析[J].护士进修杂志,2010,25(12):1063-1066. 被引量:3
-
3MacFieJ,周建烈.肠外营养2000年展望[J].中华临床营养杂志,1995,13(4):40-41. 被引量:1
-
4夏正国,戚伟伟,李兴照,蔡晨,唐益忠,章杰.ω-3多不饱和脂肪酸对严重烧伤患者心肌功能的影响[J].安徽医学,2015,36(8):934-937. 被引量:1
-
5郭淑敏,吴变梅,康晓梅.卧床患者病号服的改进与应用[J].中国药物与临床,2009,9(B11):6-6. 被引量:4
-
6李群珍,庄树彤,蔡燕娟,张茂祥,吴绍豪.多不饱和脂肪酸不同比值对结直肠癌病人术后营养状况、炎症反应和预后的影响[J].肠外与肠内营养,2013,20(4):196-198. 被引量:8
-
7谢席胜,钟翔,李静,樊均明.IgA肾病中西医循证治疗现状和展望[J].中国中西医结合肾病杂志,2008,9(4):374-376. 被引量:4
-
8王红禄,孙家邦.免疫营养在急性胰腺炎中的应用[J].国际外科学杂志,2009,36(9):614-616.
-
9吴国豪.肠外营养时脂肪乳剂的代谢及研究方法[J].肠外与肠内营养,2001,8(2):123-125. 被引量:4
-
10吴远怡,何振扬,谢贤和,谢晓红,朱永,周忠义.ω-3多不饱和脂肪酸对脓毒症患者免疫功能及近期预后的影响[J].广东医学,2011,32(17):2332-2334. 被引量:6